スポンサーリンク
メジカルビュー社 | 論文
- What's going on 頭頸部癌 Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Bernier J, Cooper JS, Pajak TF, van Glabbeke
- What's going on ゲノム Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer. Muller-Tidow C, Diederichs S, Bulk E, Pohle T, Steffen B, Schwable J, Plewka S, Thomas M, Metzger R, Schneider PM, Brandts CH, Berdel WE,
- What's going on 放射線 1)Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Olivotto IA, et al. N Engl J Med. 2004;351:963-70. PMID:15342804. 2)Lu
- Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer.Grossman HB,et al.N Engl J Med 2003;349(9):859-66--M-VAC術前療法は局所進行膀胱癌患者の生存に寄与する
- What's going on 放射線 Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, Havila
- 口内炎 (特集 支持療法の進歩--副作用・合併症対策)
- Abraxane(ABRAXANE) (特集 非選択的治療から選択的治療へのパラダイムシフト(1)) -- (細胞毒抗がん剤の組織選択性を高める方法)
- 肥満度の指標
- 脳腫瘍 (特集 化学放射線療法)
- 末梢神経障害 (特集 支持療法の進歩--副作用・合併症対策)
- What's going on 婦人科癌 Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyaraja
- What's going on 切除可能胃がんに対する術前術後化学療法が生存率向上に寄与するという論文[Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants 'Periop
- What's going on 乳癌 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group(EBCTCG). Lancet. 2005; 365: 1687-717. PMID
- イマチニブ(グリベック)--臨床応用の動向/GIST (特集 Targetを癌細胞に絞り込む分子標的治療)
- Requirement of Src kinases Lyn,Hck and Fgr for BCR-ABL 1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.Hu Y,et al.Nat Genet 2004;36:453-61.PMID:15098032--複数のフィラデルフィア染色体陽性疾患(Ph〔+〕)のなかでPh〔+〕B-ALLに特異的な造腫瘍機構の解明とその治療に対する臨床応用に足がかりをつける論文
- タイトル無し
- 閉経前乳癌の治療 (特集 分子標的のプロトタイプとしてのホルモン療法)
- What's going on 術前化学療法で奏功した食道がんを症例において、追加治療としての化学放射線療法の継続が手術に対して非劣性であることを示した無作為化臨床試験[Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, Binquet C 'Chemoradiation followed
- Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.Cooper JS,et al.for Radiation Therapy Oncology Group 9501/Intergroup.N Engl J Med 2004;350:1937-44.PMID:15128893.Postoperative irradiation wi
- What's going on 消化器癌 Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/
スポンサーリンク